Narayanan B - Search Results

1

Proline-rich AKT substrate of 40-kDa (PRAS40) in the pathophysiology of cancer.

Malla R, Ashby CR Jr, Narayanan NK, Narayanan B, Faridi JS, Tiwari AK. Malla R, et al. Among authors: narayanan nk, narayanan b. Biochem Biophys Res Commun. 2015 Jul 31;463(3):161-6. doi: 10.1016/j.bbrc.2015.05.041. Epub 2015 May 20. Biochem Biophys Res Commun. 2015. PMID: 26003731 Review.

2

Modulation of PGE2-induced EP4 expression on snail signaling and the impact on epithelial-mesenchymal transition: significance of EP4 antagonism.

Kim HN, Narayanan NK, Lasano S, Narayanan B. Kim HN, et al. Among authors: narayanan nk, narayanan b. Anticancer Res. 2011 Dec;31(12):4347-57. Anticancer Res. 2011. PMID: 22199300 Retracted.

3

Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.

Narayanan NK, Nargi D, Randolph C, Narayanan BA. Narayanan NK, et al. Int J Cancer. 2009 Jul 1;125(1):1-8. doi: 10.1002/ijc.24336. Int J Cancer. 2009. PMID: 19326431 Free article.

4

Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels.

Narayanan R, Kim HN, Narayanan NK, Nargi D, Narayanan B. Narayanan R, et al. Among authors: narayanan nk, narayanan b. Int J Oncol. 2012 Jan;40(1):13-20. doi: 10.3892/ijo.2011.1211. Epub 2011 Sep 22. Int J Oncol. 2012. PMID: 21946890 Retracted.

5

Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in a colon-26 tumor-bearing mouse model in vivo.

Narayanan NK, Kunimasa K, Yamori Y, Mori M, Mori H, Nakamura K, Miller G, Manne U, Tiwari AK, Narayanan B. Narayanan NK, et al. Among authors: narayanan b. Cancer Med. 2015 Nov;4(11):1767-80. doi: 10.1002/cam4.520. Epub 2015 Sep 26. Cancer Med. 2015. PMID: 26408414 Free PMC article.

6

Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells.

Narayanan BA, Narayanan NK, Reddy BS. Narayanan BA, et al. Among authors: narayanan nk. Int J Oncol. 2001 Dec;19(6):1255-62. doi: 10.3892/ijo.19.6.1255. Int J Oncol. 2001. PMID: 11713597

7

[Retracted] Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels.

Narayanan R, Kim HN, Narayanan NK, Nargi D, Narayanan B. Narayanan R, et al. Among authors: narayanan nk, narayanan b. Int J Oncol. 2017 Jan;50(1):337. doi: 10.3892/ijo.2016.3737. Epub 2016 Oct 18. Int J Oncol. 2017. PMID: 27779652 Free PMC article.

8

A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.

Narayanan NK, Narayanan BA, Reddy BS. Narayanan NK, et al. Int J Oncol. 2005 Mar;26(3):785-92. Int J Oncol. 2005. PMID: 15703837

9

RNA interference-mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor.

Narayanan BA, Narayanan NK, Davis L, Nargi D. Narayanan BA, et al. Mol Cancer Ther. 2006 May;5(5):1117-25. doi: 10.1158/1535-7163.MCT-05-0520. Mol Cancer Ther. 2006. PMID: 16731743

10

Anticancer effects of licofelone (ML-3000) in prostate cancer cells.

Narayanan NK, Nargi D, Attur M, Abramson SB, Narayanan BA. Narayanan NK, et al. Among authors: narayanan ba. Anticancer Res. 2007 Jul-Aug;27(4B):2393-402. Anticancer Res. 2007. PMID: 17695530 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page